Press release
Advancements in Desmoid Tumor Treatment Propel Market Growth to $3.84 Billion by 2028
Desmoid Tumor Treatment Market Report
The desmoid tumors market size is expected to see strong growth in the next few years. It will grow to $3.84 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to targeted therapies, personalized medicine, expanded international collaborations, regulatory approvals for novel therapies, patient-centric approaches. Major trends in the forecast period include advancements in treatment approaches, precision medicine and biomarker discovery, clinical trials and research initiatives, multidisciplinary treatment teams, patient advocacy and support.
Market Overview -
Desmoid tumors refer to rare non-cancerous (benign) tumors that arise from connective tissue cells, usually in the fascia, which is the tissue that surrounds muscles, nerves, and blood vessels. These tumors are locally aggressive, which means they can grow and invade nearby structures but do not spread to distant parts of the body like traditional cancer.
Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=13228&type=smp
Rising Global Cancer Incidence Fuels Growth In The Desmoid Tumor Market
The rising cases of cancer are expected to propel the growth of the desmoid tumor market going forward. Cancer refers to a collection of disorders that are defined by the body's aberrant cells growing and spreading out of control. These cells can infiltrate nearby tissues and organs and cause harm. The rising cancer cases worldwide have fueled the demand for effective and advanced chemotherapeutic agents, positively influencing the desmoid tumor market. For instance, in January 2023, according to reports published by the American Cancer Society Inc., a US-based voluntary health organization, 1.8 million new cancer cases were diagnosed in the US in 2020, and 606,520 cancer fatalities. By 2021, it was projected that the number of new cancer cases diagnosed would rise to 1.9 million, and the number of cancer deaths would increase to 608,570. Therefore, the rising cases of cancer are driving the growth of the desmoid tumor market.
Competitive Landscape -
Major companies operating in the desmoid tumors market report are Pfizer Inc., F.Hoffmann-La Roche Ltd., Abbvie Inc., Bayer AG, Novartis AG, Abbott Laboratories, Amgen Inc., Stryker Corporation, Genome And Company , Vertex Pharmaceuticals Incorporated, Eisai Limited, Beckman Coulter Inc., Incyte Corporation , Ipsen Biopharmaceuticals Inc., BeiGene Ltd., Janssen Biotech Inc., Ionis Pharmaceuticals Inc., Ayala Pharmaceuticals Inc., Blueprint Medicines Corporation, Xencor Inc., MacroGenics Inc., Debiopharm Group, Clovis Oncology Inc., Juno Therapeutics Inc., SpringWorks Therapeutics Inc., Loxo Oncology Inc., Mirati Therapeutics Inc., Iterion Therapeutics Inc., Recepta Pharmaceuticals Inc., Cellestia Biotech AG
Increasing Focus On Drug Developments To Drive The Revenues
Major companies operating in the desmoid tumors market are developing innovative drugs such as nirogacestat for the treatment of desmoid tumors to meet the needs of their existing consumers better. Nirogacestat is an oral, small-molecule gamma-secretase inhibitor. For instance, in February 2023, SpringWorks Therapeutics Inc., a US-based clinical-stage biopharmaceutical company, announced a U.S. Food and Drug Administration (FDA) acceptance and priority review of their new drug application (NDA) for nirogacestat for the treatment of adults with desmoid tumors. Nirogacestat is thought to work by blocking the production of notch proteins, which can lead to the death of tumor cells. Desmoid tumors produce high levels of notch protein, which is thought to contribute to their growth. Moreover, nirogacestat provides patients with a new treatment option that can potentially improve outcomes.
Browse Full Report @
https://www.thebusinessresearchcompany.com/report/desmoid-tumors-global-market-report
Key Segments -
The desmoid tumors market covered in this report is segmented -
1) By Treatment: Surgery, Radiation Therapy, Anti-Inflammatory Medication, Hormone Therapy, Chemotherapy, Novel Molecular-Targeted Therapy, Other Treatments
2) By Diagnosis: Biopsy, Electron Microscopic Examination, Immunohistochemical Analysis, Other Diagnosis
3) By End-User: Hospitals And Clinics, Specialty Centers, Other End-Users
Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Advancements in Desmoid Tumor Treatment Propel Market Growth to $3.84 Billion by 2028 here
News-ID: 3470878 • Views: …
More Releases from The Business Research Company
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the M …
The meal replacement market is gaining significant momentum as consumer preferences shift toward convenient and health-focused nutrition solutions. With rising awareness about preventive healthcare and personalized diets, this sector is set for considerable expansion. Let's explore how the market size is expected to evolve, who the key players are, emerging trends, and the main segments driving this growth.
Projected Growth Trajectory of the Meal Replacement Market Size
The meal replacement…
Leading Companies Reinforcing Their Presence in the Malted Barley Market
The malted barley industry is positioned for steady expansion as demand grows across various sectors. With increasing interest from craft brewers and functional food producers, this market is set to experience meaningful growth driven by innovation and sustainability efforts. Let's dive into the current market size, key players shaping the industry, trends influencing its trajectory, and detailed segment insights.
Projected Market Size and Growth Outlook of the Malted Barley Market …
Future Perspective: Key Trends Shaping the Low-calorie Food Market up to 2030
The low-calorie food market is poised for significant expansion as consumer preferences shift toward healthier eating habits and more personalized nutrition options. Advances in product innovation and supportive regulatory frameworks are expected to drive rapid growth over the coming years. Here's an overview of the market size, key players, emerging trends, and segmentation shaping this evolving industry.
Projected Expansion of the Low-calorie Food Market Size Through 2030
The low-calorie food…
Competitive Landscape: Leading Companies and New Entrants in the Liquid Nutritio …
The liquid nutritional supplement sector is on the rise, driven by evolving consumer preferences and innovations in health and wellness. With growing awareness about personalized nutrition and preventive healthcare, this market is set to witness substantial growth over the coming years. Let's explore the market's projected size, major players, emerging trends, and key segments shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Liquid Nutritional Supplement Market …
More Releases for Desmoid
Desmoid Tumors Market to Expand Significantly by 2034, States DelveInsight Repor …
DelveInsight's "Desmoid Tumors Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Desmoid Tumors, historical and forecasted epidemiology as well as the Desmoid Tumors market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Desmoid Tumors market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Desmoid Tumors Market Forecast
https://www.delveinsight.com/sample-request/desmoid-tumors-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key…
Rising Global Cancer Incidence Fuels Growth In The Desmoid Tumor Market: The Dri …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Desmoid Tumors Market Size Growth Forecast: What to Expect by 2025?
The valuation of the desmoid tumors market has experienced significant expansion recently, projected to increase from $2.97 billion in the year 2024 to reach $3.15 billion by 2025, reflecting a compound annual growth rate of 6.3%; this upward…
Desmoid Tumors Market Future Business Scope Analysis Report, Marketing Strategy, …
Introduction
The Desmoid Tumors Market focuses on a rare, locally aggressive, but non-metastatic type of soft tissue tumor that arises from fibroblasts. Also known as aggressive fibromatosis, desmoid tumors can occur anywhere in the body, but are most common in the abdomen, shoulder, and limbs. Although they do not spread to distant organs, they can cause significant morbidity due to local invasion and recurrence.
Over the past decade, treatment strategies have evolved…
Top Factor Driving Desmoid Tumors Market Growth in 2025: Rising Global Cancer In …
How Big Is the Desmoid Tumors Market Expected to Be, and What Will Its Growth Rate Be?
The desmoid tumors market is set to grow from $2.97 billion in 2024 to $3.18 billion in 2025, at a CAGR of 7.3%. Growth is driven by advancements in medical imaging, genetic research, surgical innovations, and increased awareness and education on these tumors.
The desmoid tumors market is forecast to grow strongly, reaching $4.13 billion…
Top Factor Driving Desmoid Tumors Market Growth in 2025: Rising Global Cancer In …
How Big Is the Desmoid Tumors Market Expected to Be, and What Will Its Growth Rate Be?
The desmoid tumors market is set to grow from $2.97 billion in 2024 to $3.18 billion in 2025, at a CAGR of 7.3%. Growth is driven by advancements in medical imaging, genetic research, surgical innovations, and increased awareness and education on these tumors.
The desmoid tumors market is forecast to grow strongly, reaching $4.13 billion…
Desmoid Tumors Market Strategies 2024-2033: Segments, Analysis, Trends, Opportun …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Desmoid Tumors Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $3.84 billion In 2028 At…
